Suerte, Jacinto E.

HRN: 25-09-45  Sex: Male

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
01/24/2026
PIPERACILLIN + TAZOBACTAM 2.25G (VIAL)
01/24/2026
01/31/2026
IV
2.25g
Q6hr
CAP-HR
Checking Initial Appropriateness 

 Indication:  Empiric    Type of Infection:  Pneumonia    Compliance to guidelines: Compliant To Guidelines